ライフサイエンスコーパス: peripheral

1 l modification may be combined with a second peripheral (4-chlorobiphenyl)methyl (CBP) addition to th

2 r alphabeta T cell counterparts that require peripheral activation for effector cell differentiation,

3 nce of approximately 20 Hz bursts in SM1 and peripheral activity.

4 stantially elevated protein in the CNS after peripheral administration of lipopolysaccharide (LPS).

5 This suggests that peripheral administration of OT does not lead to central

6 ncy to invade the CNS via multiple routes of peripheral administration.

7 We performed RNA-seq on purified peripheral afferent neurons, but found no striking diffe

8 Lower urinary tract reflexes are mediated by peripheral afferents from the bladder (primarily in the

9 urons also receive direct sensory input from peripheral afferents.

10 V channel isoforms are distributed along the peripheral and central branches of their bifurcated axon

11 it B of cholera toxin (CTB), we analysed the peripheral and central endings of the branch of the hypo

12 ubstantially in diet-induced obesity by both peripheral and central mechanisms.

13 ncreased levels of inflammatory cytokines in peripheral and central tissues.

14 mages may provide information for estimating peripheral and central visual function in STGD.

15 ation is limited by complex protocols, bulky peripherals, and slow operation.

16 er cohort of patients undergoing coronary or peripheral angiography with or without intervention was

17 failure, stroke, transient ischemic attack, peripheral arterial complication, and cardiac arrhythmia

18 95% confidence interval [CI]: 1.82 to 2.29), peripheral arterial disease (HR: 1.95; 95% CI: 1.72 to 2

19 er peripheral arterial revascularization for peripheral arterial disease and to assess whether readmi

20 0.722 for ADA HbA1c clinical categories for peripheral arterial disease, and 0.683 for ADA fasting g

21 CVD included CHD, stroke, heart failure, and peripheral arterial disease.

22 ovascular and surgical revascularization for peripheral arterial disease.

23 To evaluate nationwide readmissions after peripheral arterial revascularization for peripheral art

24 se and lifestyle counseling in patients with peripheral artery disease (PAD) in the United States.

25 Peripheral artery disease (PAD) is associated with incre

26 neuroischaemic if peripheral neuropathy and peripheral artery disease are both present.

27 Future peripheral artery disease cell therapy investigational t

28 red and fifty-five patients with symptomatic peripheral artery disease due to de novo superficial fem

29 lled based on previous revascularization for peripheral artery disease had higher rates of myocardial

30 Peripheral artery disease is considered to be a manifest

31 Both eGFR and ACR significantly improved peripheral artery disease risk discrimination beyond tra

32 disease conferred increased risk of incident peripheral artery disease, with a strong association bet

33 potent antiplatelet agent, in patients with peripheral artery disease.

34 eGFR] and albuminuria) with the incidence of peripheral artery disease.

35 t advance in the management of patients with peripheral artery disease.

36 disease is a risk factor for lower-extremity peripheral artery disease.

37 ng of erosions and plaques starting from the peripheral aspect within 1 to 2 weeks of treatment, and

38 Following peripheral axon injury, dysregulation of non-coding micr

39 Peripheral B and T cells are altered in pediatric patien

40 y, we observed that NKG2D deficiency affects peripheral B cell numbers.

41 the maintenance/survival of the mature naive peripheral B cell population.

42 , DAA-based therapy restored disturbances in peripheral B- and T-cell homeostasis.

43 ancements, but also for possibly identifying peripheral biomarkers that will eliminate the need for s

44 found to influence ADCY2 gene expression in peripheral blood (P = 4.50 x 10(-4)).

45 After RA SF and peripheral blood (PB) CD14+ monocytes were treated with

46 MRD was measured in peripheral blood (PB) from treatment-naive patients in t

47 Peripheral blood ADAM17 activity and soluble CD163 level

48 ype bone marrow (BM)-transplanted OS mice in peripheral blood and hematopoietic organs, such as the B

49 ffectively depleted CD20(+) B lymphocytes in peripheral blood and lymphoid tissues confirming that SG

50 ells that occur in HIV infection both in the peripheral blood and lymphoid tissues, especially in the

51 factors was analyzed in CD4(+) T cells from peripheral blood and the jejunum in rhesus macaques, rev

52 0.0218) and the proviral copy number in the peripheral blood as an indirect measure of partial viral

53 Flow cytometric analysis of peripheral blood B cells of 30 MC-negative HCV-infected

54 ion of BDNF in SCZ, especially the decreased peripheral blood BDNF levels in SCZ patients validated b

55 t (TME), the presence of maternal T cells in peripheral blood before transplantation, is detectable i

56 ion at midlife and a concomitant increase in peripheral blood blast cells.

57 Mast cells were cultured from peripheral blood CD34(+) cells and examined for releasab

58 flammatory cytokine expression in stimulated peripheral blood CD4+ T cells and ex vivo human skin, an

59 also increased the inflammatory potential of peripheral blood cells after lunch.Compared with 3 meals

60 Xenogeneic peripheral blood chimerism was assessed after each infus

61 (ICN1) is detectable in approximately 50% of peripheral blood CLL cases lacking gene mutations.

62 osections were incubated with purified human peripheral blood eosinophils with or without activation

63 We evaluated aeroallergen sensitization, peripheral blood eosinophils, and serum periostin as pot

64 sitively with living on a farm and increased peripheral blood forkhead box protein 3 expression and c

65 Here we show that human peripheral blood IFN-gamma(+)IL-17(+) (TH1/17) and IFN-g

66 e likely role of DNA methylation measured in peripheral blood in the etiology of type 2 diabetes.

67 The presence and degree of peripheral blood involvement in patients with cutaneous

68 We analyzed: (1) peripheral blood leukocyte levels and immune responses;

69 ofluidic device that isolates and enumerates peripheral blood lymphoblasts using affinity separations

70 fluorescent InsB10-23:DQ8 tetramers, stained peripheral blood lymphocytes directly ex vivo, and show

71 Peripheral blood monocytes play a role in sarcoidosis in

72 ll subjects remained off ERT with normalized peripheral blood mononuclear cell (PBMC) ADA activity, i

73 Suppression of parasite-specific peripheral blood mononuclear cell (PBMC) proliferation w

74 SCs deliver miR-9 to the injured pancreas or peripheral blood mononuclear cell (PBMC), which can targ

75 Neutralizing antibodies were detected in a peripheral blood mononuclear cell assay, and moderate an

76 d an allogeneic HCT and had archived pre-HCT peripheral blood mononuclear cell samples.

77 al human MCF10A mammary epithelial and human peripheral blood mononuclear cells (PBMC) by MTT assay.

78 Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both huma

79 f CCR5 does not prevent ex vivo infection of peripheral blood mononuclear cells (PBMC) from SM or ver

80 irus (CMV)-pp65-specific T-cell responses in peripheral blood mononuclear cells (PBMCs) and breast mi

81 c induction in freshly isolated B cells from peripheral blood mononuclear cells (PBMCs) and that acti

82 L-17-positive T cells were sorted from human peripheral blood mononuclear cells (PBMCs) by intracellu

83 In this study, we screened peripheral blood mononuclear cells (PBMCs) from donors v

84 d DNA methylation at baseline and 3 hours in peripheral blood mononuclear cells (PBMCs) using the Inf

85 In an analysis of peripheral blood mononuclear cells and intestinal tissue

86 al and noncanonical pathways was examined in peripheral blood mononuclear cells and transfected HEK29

87 ytometry in a mimetic cell mixture and human peripheral blood mononuclear cells as model systems.

88 OLM-4, THP-1 or primary AML cells with donor peripheral blood mononuclear cells elicited a cell conta

89 Peripheral blood mononuclear cells from healthy controls

90 inhibited IFN-gamma and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART

91 sy samples and Leishmania antigen-stimulated peripheral blood mononuclear cells from patients infecte

92 ve TLR7 agonist, GS-9620, activated HIV from peripheral blood mononuclear cells isolated from HIV-inf

93 , combined delivery of ICOVIR-15K-cBiTE with peripheral blood mononuclear cells or T cells enhanced t

94 By contrast, the patient's peripheral blood mononuclear cells responded normally to

95 In vitro secretion of these miRNAs by peripheral blood mononuclear cells was also significantl

96 Plasma and peripheral blood mononuclear cells were collected at mul

97 Peripheral blood mononuclear cells were obtained at week

98 DNA genotyping and mRNA expression levels in peripheral blood mononuclear cells were quantified via m

99 wide range of cancers, does not bind normal peripheral blood mononuclear cells, and can activate imm

100 ntiation of CD4+ T cells isolated from human peripheral blood mononuclear cells.

101 vo than either GG or AG (p < 0.001) in total peripheral blood mononuclear cells.

102 phatase-1 were determined in neutrophils and peripheral blood mononuclear cells.

103 cyte-derived dendritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelial and i

104 Knockdown of LY6E in human peripheral blood mononuclear, SupT1, and THP-1 cells dim

105 Peripheral blood NK cells from individuals with GATA2 mu

106 lpha, whereas IL-10 levels were increased in peripheral blood of clinical responders after 12 wk of t

107 /TH17CM) cells were selectively increased in peripheral blood of patients with relapsing-remitting MS

108 lower in other human TILs and in many human peripheral blood populations.

109 factor expression in this subset relative to peripheral blood prior to infection.

110 Peripheral blood samples from patients with ALF had a hi

111 Peripheral blood samples were obtained for HIV antibody

112 mor-free liver tissues (control tissues) and peripheral blood samples.

113 A peripheral blood smear revealed anemia, thrombocytopenia

114 nulocyte colony-stimulating factor-mobilized peripheral blood stem cell donor grafts and successful t

115 ion, we show that mast cell progenitors from peripheral blood survive, mature, and proliferate withou

116 g clinical symptoms and biospecimens such as peripheral blood to be collected.

117 methylation (DNAm) data from cord blood and peripheral blood to identify SNPs associated with DNA me

118 tion state of eosinophils and neutrophils in peripheral blood to phenotype and monitor asthma.

119 promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo.

120 Interestingly, most ( approximately 60%) peripheral blood Treg cells express CCR6, and CCR6(+) Tr

121 Patients with higher peripheral blood viral loads in primary infection and gr

122 Peripheral blood was collected from 70 virally suppresse

123 tic tool to quantify L. loa microfilariae in peripheral blood, enables rapid, point-of-care identific

124 exhibit increased presence of MDSCs in their peripheral blood, in comparison with normal controls.

125 encing on 5,063 single T cells isolated from peripheral blood, tumor, and adjacent normal tissues fro

126 AIH/AISC we noted a substantial increase in peripheral blood-derived CD4(+) CD127(+) CD25(high) cell

127 was absent in nondiseased liver tissues and peripheral blood.

128 missing heritability for gene expression in peripheral blood.

129 cific to each, as well as their abundance in peripheral blood.

130 ve more Treg cells, IL-33 and IL-10 in their peripheral blood.

131 within noninvaded lymph nodes and absent in peripheral blood.

132 ene levels were measurable up to 780 days in peripheral blood.

133 red balance of lymphoid and myeloid cells in peripheral blood.

134 sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with

135 internalization, and degradation in MDCK and peripheral bud cells for regulating cell dynamics.

136 ather than having the pyridyl core as in the peripheral cavities.

137 f memory and naive CD4 T cells occurred, and peripheral CD4 and CD8 T cells had reduced chemoattracta

138 Future longitudinal studies of peripheral changes in AMD and their impact on visual fun

139 ransmitter acetylcholine at both central and peripheral cholinergic synapses, including the neuromusc

140 rkers of the human master clock and multiple peripheral circadian rhythms.

141 itical role in cholesterol transport in both peripheral circulation and brain.

142 This misalignment of central and peripheral clocks may be involved in the development of

143 ase with the light schedule, may synchronize peripheral clocks.

144 mmune cells from the CNS and meninges to the peripheral (CNS-draining) lymph nodes.

145 selves exhibited slower light responses than peripheral cones, unexpectedly linking cone signals to p

146 comes after toric intraocular lens (tIOL) or peripheral corneal relaxing incisions (PCRI) for keratom

147 on occur as a downstream mechanism following peripheral deficit.

148 ntion at the point of gaze and filtering out peripheral distractors when the task required a narrow f

149 However, until primed by inflammation, peripheral DOR is analgesically incompetent, raising int

150 marily mediated by the interaction between a peripheral element of the RNA that forms a T-loop module

151 Peripheral elevation of [Ca(2+) ]i initiates CICR from n

152 us displayed a very low rate of stroke (0%), peripheral embolism (0%), and severe hemorrhage (n = 1,

153 functional reorganization of the central and peripheral EVC following visual field defects specifical

154 at we may, in fact, already be targeting the peripheral EVS.

155 These findings suggest that peripheral expansion of induced Treg cells can serve as

156 increase, P < 0.0001) were identified in the peripheral fields of the UWF images.

157 e in the proportion and number of thymic and peripheral Foxp3(+) regulatory T cells.

158 as estimated at the same test locations from peripheral grating resolution acuity thresholds.

159 ndent of deacetylase activity, Hdac3 tethers peripheral heterochromatin containing lineage-relevant g

160 yocytes is associated with reorganization of peripheral heterochromatin, and independent of deacetyla

161 Furthermore, VISTA regulates the peripheral homeostasis of CD27(-) gammadelta T cells and

162 Peripheral IL-1 inhibition using anakinra for 4 weeks do

163 steady-state conditions, tau-tg mice exhibit peripheral immune activation that is manifested by highe

164 Microbes also influence the activation of peripheral immune cells, which regulate responses to neu

165 of astrocytes as key intermediaries between peripheral immune events, neuronal processing, and poten

166 iew, we discuss the role of CNS-resident and peripheral immune pathways in microbiota-gut-brain commu

167 bed fear conditioning/extinction or utilized peripheral immune, sleep, and noninvasive imaging measur

168 Using a model of peripheral infection of mice with HSV-1, we have charact

169 modulate amyloid pathology as a regulator of peripheral inflammation.

170 on of complete Freund's adjuvant, a model of peripheral inflammatory pain.

171 The selectivity in its peripheral inhibitory action may partly account for frem

172 haS transgenic mice through intracerebral or peripheral injection of various mutant alphaS fibrils.

173 elops when beta-cells are unable to adapt to peripheral insulin demands.

174 f ischemia, and predilection for venules and peripheral involvement.

175 .3 and that depletion of Repo-Man alters the peripheral localization of a subset of these regions and

176 leterious, we challenged Lcn2(-/-) mice with peripheral LPS and determined effects on behavior and ne

177 A specific "peripheral lymphocyte signature" observed in patients wi

178 tion were unaffected by PLX5622 treatment or peripheral macrophage depletion by clodronate liposome t

179 Here we show that replacing the peripheral macrophage populations of wild-type mice with

180 These studies establish that peripheral markers of FGF2 concentrations are negatively

181 A comparison with other peripheral membrane proteins elucidates common and speci

182 migrate out of the spinal cord and myelinate peripheral motor axons, we assayed perineurial glial dev

183 e first cell types to encounter virus in the peripheral mucosal tissues.

184 type 1A (CMT1A) is caused by duplication of peripheral myelin protein 22 (PMP22) and is the most com

185 ells in the injured spinal cord; invasion of peripheral myelinating (P0+) Schwann cells made only a l

186 nisms that are regulated by NECL4 and affect peripheral myelination currently remain unclear.

187 for the first time, that the excitation of a peripheral nerve can be accomplished by 12-ns PEF withou

188 ent herpes simplex virus (HSV) reactivation, peripheral nerve destruction and sensory anesthesia are

189 anglia (DRG), the morphology and location of peripheral nerve endings of spinal afferents that transd

190 for both the development and maintenance of peripheral nerve function.

191 Mechanistically, peripheral nerve injury induces DNA demethylation and up

192 There is consensus that, distal to peripheral nerve injury, myelin and Remak cells reorgani

193 ake meaningful comparisons between different peripheral nerve interfaces.

194 LV2-14 patients were more likely to have peripheral nerve involvement, an intact circulating immu

195 To detect and quantify peripheral nerve lesions in multiple sclerosis (MS) by m

196 we hypothesize that injection of ATP into a peripheral nerve might mimic the stimulatory effect of n

197 and secreted by Schwann cells that regulates peripheral nerve myelination via its cognate receptor AD

198 K3(S/A) knock-in mice reportedly accelerates peripheral nerve regeneration via increased MAP1B phosph

199 Malignant peripheral nerve sheath tumors (MPNSTs) are devastating

200 c sarcomas, myxofibrosarcomas, and malignant peripheral nerve sheath tumors are characterized by comp

201 -fixed, paraffin-embedded specimens of human peripheral nerve sheath tumors.

202 Finally, we introduce a preparation of peripheral nerve slices for patch-clamp recordings.

203 Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann ce

204 macrophage communication after damage to the peripheral nerve.

205 tion.SIGNIFICANCE STATEMENT Although injured peripheral nerves contain repair Schwann cells that prov

206 ings and videography to identify central and peripheral nerves responsible for nociception and sensit

207 polyneuropathy, which primarily affects the peripheral nerves, and transthyretin cardiomyopathy (TTR

208 ation.SIGNIFICANCE STATEMENT After injury to peripheral nerves, the myelin and Remak Schwann cells di

209 chanosensory and chemosensory neurons of the peripheral nervous system (PNS) must signal to the motor

210 In the peripheral nervous system (PNS), developmental axon prun

211 0 years, 1.64; 95% CI, 1.19-2.27; P = .003), peripheral nervous system involvement (HR, 6.75; 95% CI,

212 Schwann cell (SC) myelination in the peripheral nervous system is essential for motor functio

213 ectual disability and additional central and peripheral nervous system symptoms but an absence of fro

214 erivatives including neurons and glia of the peripheral nervous system, melanocytes, and bone and car

215 physiology, and for treating diseases of the peripheral nervous system, such as chronic nausea, vomit

216 marcate an itch-specific labeled line in the peripheral nervous system.

217 an undecapeptide present in the CNS and the peripheral nervous system.

218 rodevelopment and maintenance of central and peripheral nervous systems.

219 egeneration in the CNS and in the context of peripheral neuropathies.

220 rtriglyceridaemia (21 [39%] of 54 patients), peripheral neuropathy (21 [39%] of 54 patients), and per

221 Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting s

222 a preclinical model of chemotherapy-induced peripheral neuropathy (CIPN), the most common treatment-

223 Ulcers are deemed neuroischaemic if peripheral neuropathy and peripheral artery disease are

224 Concurrent peripheral neuropathy has been recognised in association

225 Pirenzepine and MT7 also prevented peripheral neuropathy induced by the chemotherapeutic ag

226 at least 5 cm and without grade 2 or greater peripheral neuropathy were included in the study.

227 Diabetic kidney disease, retinopathy, peripheral neuropathy, cardiovascular autonomic neuropat

228 r arthralgia, vomiting, nausea, fatigue, and peripheral neuropathy, whereas edema was more frequent a

229 s dosing to minimize adverse events, such as peripheral neuropathy.

230 22 (PMP22) and is the most common hereditary peripheral neuropathy.

231 isodic CNS clinical syndromes in addition to peripheral neuropathy.

232 y to protect against anticancer drug-induced peripheral neurotoxicity.

233 pe and anti-fibrotic function of hepatic and peripheral NK subsets in 43 HBV-LC patients.

234 imal discrimination of inputs applied at the peripheral nodes.

235 which fires in response to a noisy input at peripheral nodes.

236 al neuropathy (21 [39%] of 54 patients), and peripheral oedema (21 [39%] of 54 patients).

237 tory system is a natural biosensor since its peripheral olfactory sensory neurons (OSNs) respond to t

238 roadly classified based upon their maturity (peripheral or mature versus precursor) and lineage (B ce

239 As are endogenously present in rat brain and peripheral organs as determined via targeted lipidomics

240 systems, including the spinal cord and other peripheral organs.

241 and enhanced bacterial clearance in multiple peripheral organs.

242 in postmortem PD brains and assessed whether peripheral p11 levels correlate with disease severity.

243 Peripheral p11 protein levels were investigated in disti

244 Peripheral pain signaling reflects a balance of pronocic

245 The two primary theories of peripheral pitch coding involve stimulus-driven spike ti

246 from computer vision with a recent model of peripheral pooling regions found at the V1 layer of the

247 Zinc(II) phthalocyanine fused in peripheral positions octa-substituted with alkyl linked

248 oles, both at the inner core, as well as the peripheral positions of the macrocycle.

249 nd simulated 512-electrode recordings in the peripheral primate retina with single-electrode and seve

250 VP40 (mVP40) has been shown to be a dimeric peripheral protein with a broad and flat basic surface t

251 The latter complex partitioned to a peripheral region of the nucleus, as shown by super-reso

252 ector sites of oral tolerance by suppressing peripheral regulatory T cell (pTreg) conversion and prom

253 Drusen and RPE changes were seen in the peripheral retina, anterior to the vortex veins, in 21.8

254 from 250 (near the fovea) to 1,000 microm in peripheral retina.

255 on of development in the fovea compared with peripheral retina.

256 Peripheral retinal changes are more prevalent in eyes wi

257 central scotoma, group 1, and 30 affected by peripheral scotoma, group 2.

258 These observations indicate that blocking peripheral sensory input may prevent BTP and targeting c

259 As in the cell body and axon compartments of peripheral sensory neurons and the 3' untranslated regio

260 However, a peripheral site of action is indicated by the ability of

261 pose a model in which Treg cell responses at peripheral sites converge on those self-proteins that ar

262 eurodevelopment at embryonic day E14.5, when peripheral sources of 5-HT predominate, and E18.5, when

263 by the relative positions of the central and peripheral stalks affects c-subunit stepping efficiency.

264 tal nucleus (RMTg) regions were activated by peripheral stimulation and LHb lesions reversed the inhi

265 ry effects on cocaine locomotion produced by peripheral stimulation.

266 oral lymphocytes prior to treatment or among peripheral T cells after treatment would be associated w

267 eficient mice, which show a complete lack of peripheral T cells.

268 oiesis and development of new thymus-derived peripheral T cells.

269 frequencies of CD4 T cell subsets, including peripheral T follicular helper (pTfh) cells, which provi

270 se kinetics and, by doing so, it reduces the peripheral temporal resolution in coding odor stimuli an

271 ss visual morbidity in patients with DR at a peripheral tertiary eye care center of Nepal.

272 controls human female reproductive tract and peripheral tissue dynamics in single, dual and multiple

273 at steady-state levels of ATP7A are lower in peripheral tissues (including the heart, spleen, and liv

274 not been shown whether lipid oscillations in peripheral tissues are driven by diurnal cycles of rest-

275 glia and then to reactivate and move back to peripheral tissues for spread to other hosts.

276 illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-depe

277 involved in a growing number of functions in peripheral tissues.

278 , for the first time, a distinctive role for peripheral TNF-alpha in the modulation of the amyloid ph

279 4-5 kJ/mol/protomer in the N3 domain that is peripheral to the membrane-spanning C domain in the dode

280 4 and IL-13 contribute to the maintenance of peripheral tolerance and whether their function is coord

281 with disease, the most common seem to affect peripheral tolerance rather than central tolerance.

282 s (Tregs) play a pivotal role in maintaining peripheral tolerance.

283 in TCR signaling to enforce both central and peripheral tolerance.

284 ver, because its development was hampered by peripheral toxicities.

285 tor CD69 controls tTreg cell development and peripheral Treg cell homeostasis through the regulation

286 Previous studies suggest that peripheral tumors elicit central pro-inflammatory cytoki

287 Of 3096 acute cerebral or peripheral vascular events, 748 (24.2%) were AF-related.

288 in cardiac contractility with an exaggerated peripheral vasoconstriction in the CHF state.

289 m the limitations of short dosing intervals, peripheral vasodilation, unwanted side effects, and rest

290 acterization of circulating tumor cells from peripheral venous blood in clinical practice.

291 direct evidence of an effective treatment of peripheral vestibular function in a mouse model of USH1C

292 ion of the cholinergic efferents innervating peripheral vestibular hair cells.

293 oid disease may occur following clearance of peripheral virus in ZIKV-infected individuals.

294 ifference, 16.3; 95% CI, 0.9-31.7; P = .04), peripheral vision (difference, 11.6; 95% CI, 0.8-22.4; P

295 ld defects specifically affecting central or peripheral vision.

296 ight blindness, and 56% (14/25) with loss of peripheral vision.

297 the association of choroidal thickness and "peripheral vision." The strongest association was the LL

298 of two representative voxels (isocenter and peripheral voxel of the tumor) are computed and compared

299 underwent bronchoalveolar lavage (BAL), and peripheral whole blood was collected into PAXgene tubes

300 Specifically, peripheral ZIKV infection of pregnant AIR females result